ConductScience.org, home

Paper41006824

Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.

Diaz LA and 29 others. Nat Rev Gastroenterol Hepatol, 2025. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease. Papers, record 41006824. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41006824

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.
PubMed
Journal
Nat Rev Gastroenterol Hepatol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
6.52, provisional
iCite
Revised in PubMed
2026-11-05
PubMed

Authors30

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Diaz LALuis Antoniohttps://orcid.org/0000-0002-8540-4930
2Thiele MMajahttps://orcid.org/0000-0003-1854-1924
3Louvet AAlexandrehttps://orcid.org/0000-0002-5293-007X
4Lee BPBrian Phttps://orcid.org/0000-0003-2108-1287
5Ajmera VVeeralhttps://orcid.org/0000-0001-5626-0942
6Tavaglione FFedericahttps://orcid.org/0000-0002-1720-4355
7Hsu CLCynthia Lhttps://orcid.org/0000-0002-2604-1340
8Huang DQDaniel Qhttps://orcid.org/0000-0002-5165-5061
9Pose EElisa
10Bataller RRamonhttps://orcid.org/0000-0002-1119-7799
11McClain CCraig
12Mellinger JJessica
13Tincopa MMonica
14Mitchell MCMack Chttps://orcid.org/0000-0001-9018-7988
15Ratziu VVlad
16Rinella MEMary Ehttps://orcid.org/0000-0003-0620-9705
17Sarin SKShiv Khttps://orcid.org/0000-0002-0544-5610
18Shah VHVijay Hhttps://orcid.org/0000-0001-7620-573X
19Szabo GGyongyi
20Wong VWVincent Wai-Sun

Source PubMed

See all 30 authorsDownload CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Clinical Trials as TopicMajor topic
Research DesignMajor topic
Liver Diseases, AlcoholicMajor topic
Humans
Biomarkers
Alcohol Drinking
Endpoint Determination

Source PubMed

Download CSV of topics

References228

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130658728Non-invasive diagnosis and biomarkers in alcohol-related liver disease.J Hepatol2019https://conductscience.org/library/papers/30658728PubMed
234027340Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets.JHEP Rep2021https://conductscience.org/library/papers/34027340PubMed
311172192Liver biopsy.N Engl J Med2001https://conductscience.org/library/papers/11172192PubMed
424848614Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease.Alcohol Clin Exp Res2014https://conductscience.org/library/papers/24848614PubMed
532125254Liver Stiffness Measured with Two-dimensional Shear-Wave Elastography Is Predictive of Liver-related Events in Patients with Chronic Liver Disease Due to Hepatis B Viral Infection.Radiology2020https://conductscience.org/library/papers/32125254PubMed
631169533Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.Am J Gastroenterol2019https://conductscience.org/library/papers/31169533PubMed
738881524Relationship between alcohol intake based on daily smartphone-reported consumption and PEth concentrations in healthy volunteers.Alcohol Alcohol2024https://conductscience.org/library/papers/38881524PubMed
837236193The enteric nervous system relays psychological stress to intestinal inflammation.Cell2023https://conductscience.org/library/papers/37236193PubMed
938851997EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).J Hepatol2024https://conductscience.org/library/papers/38851997PubMed
1030458263Randomized trial seeking to induce the Hawthorne effect found no evidence for any effect on self-reported alcohol consumption online.J Clin Epidemiol2019https://conductscience.org/library/papers/30458263PubMed
1134626833Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis.Clin Gastroenterol Hepatol2022https://conductscience.org/library/papers/34626833PubMed
1234168277Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity.Int J Obes (Lond)2021https://conductscience.org/library/papers/34168277PubMed
1337992972Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes.J Hepatol2024https://conductscience.org/library/papers/37992972PubMed
1435120736Baveno VII - Renewing consensus in portal hypertension.J Hepatol2022https://conductscience.org/library/papers/35120736PubMed
1535843374Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design.J Hepatol2022https://conductscience.org/library/papers/35843374PubMed
1625557690
Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop.
Hepatology2015https://conductscience.org/library/papers/25557690PubMed
1738560775Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients.Liver Int2024https://conductscience.org/library/papers/38560775PubMed
1838702474A physiologically-based digital twin for alcohol consumption-predicting real-life drinking responses and long-term plasma PEth.NPJ Digit Med2024https://conductscience.org/library/papers/38702474PubMed
1932097176The utility of liver biopsy in 2020.Curr Opin Gastroenterol2020https://conductscience.org/library/papers/32097176PubMed
2036881347Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUD.Obes Surg2023https://conductscience.org/library/papers/36881347PubMed

See all 228 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
42939612Glycine Insufficiency as a Metabolic Vulnerability in MASLD: Implications for Precision Nutrition.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42939612PubMed
42882113Physical Activity and Mediterranean Diet Adherence in Patients with Metabolic Syndrome and Alcohol-Related Liver Disease: A 12-Month Prospective Study.J Clin Med2026https://conductscience.org/library/papers/42882113PubMed
42783733MetALD Molecular Signatures: What We Know, What We Lack, and How to Move Forward Through Integrated Multi-Omics.Metabolites2026https://conductscience.org/library/papers/42783733PubMed
42732486Noninvasive surrogate endpoints in MASH trials: current perspectives and challenges.Hepatol Int2026https://conductscience.org/library/papers/42732486PubMed
42706034[Considerations on clinical trial issues related to new drug development for metabolic and alcohol-associated liver disease and fatty liver disease].Zhonghua Gan Zang Bing Za Zhi2026https://conductscience.org/library/papers/42706034PubMed
42613422Global epidemiology of metabolic and alcohol-associated liver disease: risk factors, natural history and clinical implications.Nat Rev Gastroenterol Hepatol2026https://conductscience.org/library/papers/42613422PubMed
42578314MAFLD/MASLD: Past, Present, and Future.J Gastroenterol Hepatol2026https://conductscience.org/library/papers/42578314PubMed
42511850Circulating Adipokines in Alcohol-Related Liver Disease and MetALD: A Systematic Review and Structured Narrative Synthesis.Int J Mol Sci2026https://conductscience.org/library/papers/42511850PubMed
42475412Therapeutics for Alcohol-Associated Liver Disease.Annu Rev Pharmacol Toxicol2026https://conductscience.org/library/papers/42475412PubMed
42414592Advancing liver health in a shifting global landscape.Nat Rev Gastroenterol Hepatol2026https://conductscience.org/library/papers/42414592PubMed
42156626Clinical trial endpoints for metabolic dysfunction and alcohol associated steatotic liver disease.Hepatol Int2026https://conductscience.org/library/papers/42156626PubMed
42120953Subtype Differences in Major Adverse Liver Outcomes and Cardiovascular Events and Mortality in Steatotic Liver Disease: A UK Biobank Analysis.Aliment Pharmacol Ther2026https://conductscience.org/library/papers/42120953PubMed
42044878Predictive modeling and clinical decision tools for risk stratification in steatotic liver disease.Clin Mol Hepatol2026https://conductscience.org/library/papers/42044878PubMed
41899181Alcohol Abstinence Is Associated with Regression of Non-Invasive Fibrosis Markers in Patients with Metabolic Syndrome: A 12-Month Prospective Study.J Clin Med2026https://conductscience.org/library/papers/41899181PubMed
41851447Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management.Nat Rev Gastroenterol Hepatol2026https://conductscience.org/library/papers/41851447PubMed
41596657Molecular and Regenerative Effects of Platelet-Rich Plasma and Related Hemocomponents in Animal Models of Liver Injury-A Systematic Review.Int J Mol Sci2026https://conductscience.org/library/papers/41596657PubMed
41459093Metabolic dysfunction and alcohol-associated liver disease (MetALD).eGastroenterology2025https://conductscience.org/library/papers/41459093PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41006824

GET https://conductscience.org/api/papers/v1/41006824/authors?page=2